Why I’m here for you

“Every person and couple with infertility requires a unique, personalized approach for treatment. Each plan must take into account both the medical and physical circumstances as well as personal feelings regarding the treatment options.”
 
 

Specialties

  • Reproductive Endocrinology and Infertility
  • Assisted Reproductive Technologies (ART, Including IVF, ICSI, PGT)
  • Fertility Preservation (Egg Freezing)
  • Third-Party Fertility (Donor Egg/Sperm)
  • Male & Female Infertility

Teaching the REIs of tomorrow

  • Faculty/teacher: Assistant Professor (clinical) in Department of Obstetrics and Gynecology Louisiana State University Health Sciences Center, School of Medicine

Fertility training

  • Education: Georgetown University, School of Medicine in Washington, D.C., M.D.
  • Residency: Louisiana State University Medical Center in New Orleans, OB-GYN
  • Fellowship: Mayo Clinic and Foundation in Rochester, Minnesota, Obstetrics and Gynecology and Reproductive Endocrinology
 

About Dr. Peter Lu

Dr. Peter Lu has been in practice since 1996 and specializes in reproductive endocrinology & infertility. He chose this field of medicine because infertility treatment utilizes a combination of medication, surgery and advanced laboratory technologies to achieve successful pregnancies. Additionally, he feels there is significant emotional stress and distress associated with fertility problems, which also need to be addressed in all treatment plans.

Dr. Lu is board certified in OB-GYN and reproductive endocrinology & infertility (REI). His areas of clinical focus include all assisted reproductive technologies (ART) including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), fertility preservation by egg freezing, donor egg treatment, donor sperm insemination and intrauterine insemination (IUI). He also treats infertility caused by tubal disease, endometriosis, polycystic ovary syndrome (PCOS), male factor infertility and low ovarian reserve.

Approach to treatment

Dr. Lu believes his greatest strength interacting with patients is explaining the complexities of problems and solutions in an understandable way. He wants his patients to be clear about all aspects of their fertility treatment including the rationale for their “game plan,” with a successful pregnancy as the ultimate reward.

“I focus on the four “Ds” of patient care: data, decision, diagnosis, DOING something.”

Dr. Lu enjoys the challenge of evaluating and finding out why a couple is not conceiving and creating a customized treatment plan with clear next steps. He is proud of building trusting relationships with patients based on mutual respect, which is a key component of being able to embark on the challenging task that is fertility treatment.

On a personal note

Dr. Peter Lu Enjoying Fishing

Dr. Lu’s hobbies range from the relaxing tranquility of fly fishing to the excitement of motorcycle riding.

He is also interested in mental and physical fitness and wellness.

Awards, boards, honors, publications & abstracts

Dr. Lu is active on several hospital and university committees and in other professional organizations such as the American Society for Reproductive Medicine. He has also received several honors and awards and has made numerous presentations. His professional activities, publications and articles follow.

Honors

  • Alpha Lambda Delta Honor Society, Cornell University, College of Arts and Sciences, 1981
  • American Fertility Society/Wyeth Ayerst Resident Reporter, 48th Annual Meeting, New Orleans, 1992
  • AAGL Outstanding Resident in Gynecologic Laparoscopy, 1993
  • First Prize Resident Paper ACOG District VII Louisiana Section 14th Annual Meeting, New Orleans, 1993
  • Achievement Award for Highest HO IV 1993 CREOG Score, Department of Obstetrics and Gynecology, Louisiana State University Medical School, New Orleans, 1993
  • Section of Infectious Diseases Resident Recognition Award, Department of Obstetrics and Gynecology, Louisiana State University Medical School, New Orleans, 1991

Top Doc Awards

  • Voted Top Doctor by New Orleans Magazine, 2009, 2010 and 2011
  • Voted Best Doctor by New Orleans Magazine, 2012-2020
  • Voted Best Doctor for Fertility (second most votes), “Best Docs 2008,” NOLA Baby & Family Magazine, 2008-2012
  • Voted “Louisiana’s Top Docs: The Latest Results,” Louisiana Life Magazine, 2009- 2013
  • Voted Best Fertility Doctor, “Northshore’s Best, Sophisticated Woman, 2015

Current society memberships

  • American College of Obstetrics & Gynecology (ACOG)
  • American Society for Reproductive Medicine (ASRM)
  • Society of Reproductive Endocrinologists (SRE)
  • Society of Reproductive Surgeons (SRS)
  • Louisiana State Medical Society
  • New Orleans Society of Obstetrics and Gynecology
    • Executive Committee Member-At-Large, 2012-2014
    • Secretary Treasurer, 2014-2019
  • Orleans Parish Medical Society

Publications

  1. Bey MA, Pastorek JG, Lu PY, Gabert HA, Letellier RL, Miller JM Jr: Comparison of morbidity in cesarean section hysterectomy versus cesarean section tubal ligation. Surg Gynecol Obstet 1994;177:357-60.
  2. Book review: “Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management,” third edition. Yen SCC, Jaffe RB, editors.  Fertil Steril 1994;61:198-9.
  3. Lu PY, Raj M, Elkins TE: Nonbarrier surgical adjuvants used in reduction of postoperative adhesion formation. Infertility and Reproductive Medicine Clinics of North America. Leach RE, editor. 1994;5:445-61.
  4. Book review:  “Women and Exercise: Physiology and Sports Medicine,” second edition, Shangold M, Mirken G (editors).  Fertil Steril.  1994;62:213-4.
  5. Lu PY, Hammitt DG, Zinsmeister AR, Dewald GW. Dual color fluorescence in situ hybridization to investigate aneuploidy in sperm from 33 normal males and a man with a t(2;4;8)(q23;q27;p21).  Fertil Steril 1994;62:394-9.
  6. Lu PY, Ory SJ.  Current Management of Endometriosis.  Mayo Clinic Proceedings 1995;70:453-63.
  7. Book review:  “Infertility: Evaluation and Treatment,” Keye WR, Chang RJ, Rebar RW, Soules MR (editors). 1995, WB Saunders Co., Philadelphia, Mayo Clinic Proceedings 1995;70:1022.
  8. Gist RS, Lu PY, Raj HGM, Campbell C, Elkins TE. Use of sodium hetastarch (hespan) solution for reduction of postoperative adhesion formation in rabbits. J Invest Surg 1996;9:369-373.
  9. Krahn LE, Lu PY, Klee G, Lin SC, Zimmermann RC. Examining seratonin function: a new technique for rapid tryptophan depletion. Neuropsychopharmacology 1996;15:325-328.
  10. Lu PY, Atkinson EJ, Chen ALJ, Lee SH, Erickson LD, Ory SJ. Minimal stimulation achieves pregnancy rates comparable to human menopausal gonadotropins in the treatment of infertility.  Fertil Steril 1996;65:583-7.
  11. Book review: “Reproductive Endocrinology, Surgery, and Technology,“ Adashi EY, Rock JA, Rosenwaks Z (editors), 1995 Lippincott-Raven, Philadelphia in Fertil Steril (in press).
  12. Rhoton-Vlasak AR, Lu PY, Barud KM, Dewald GW, Hammitt DG.  Efficacy of calcium ionphore A23187 oocyte activation for generating parthenotes for human embryo research. J Assist Reprod Genetics 1996;13:793-796.
  13. Lu PY, Pastorek JG, Letellier RL, Bey MA. A comparison of elective and emergency cesarean hysterectomy on a teaching service – 1981 to 1991. Southern Med J 1997;90:50-54.
  14. Dickey RP, Taylor SN, Curole DN, Rye P, Lu, PY, Pyrzak R. Relationship of clomiphene dose and patient weight to successful treatment.  Hum Reprod 1997;12:449-53.
  15. Dickey RP, Taylor SN, Curole DN, Rye PH, Lu PY. Ovulation induction and IUI in older women (letter; comment).  Hum Reprod 1997;12:1991.
  16. Dickey RP, Taylor SN, Curole DN, Rye PH, Lu PY. The king, his knights, and type I errors (letter; comment). Fertil Steril 1997;66:863-865.
  17. Dickey RP, Taylor SN, Rye PH, Lu PY. A role for clomiphene in the 21st century? Hum Reprod 1998;13:361-362.
  18. Dickey RP, Taylor SN, Rye PH, Lu PY, Pyrzak R. Comparison of sperm quality resulting in successful intrauterine insemination to World Health Organization threshold values for normal sperm. Fertil Steril 1999;71:684-689.
  19. Dickey RP, Taylor SN, Rye PH, Lu PY, Sartor BM. Infertility is a symptom, not a disease.  Fertil Steril 2000;74:398.
  20. Dickey RP, Pyrzak R, Taylor SN, Rye PH, Lu PY, Sartor BM. Relationship of follicle numbers and estradiol levels to multiple implantation in 3608 intrauterine insemination cycles. Fertil Sterl 2001;75:69-89.
  21. Dickey RP, Pyrzak R, Taylor SN, Rye PH, Lu PY, Sartor BM. Decision to do IUI or IVF – sperm count. Fertil Steril 2001;76:1086.
  22. Dickey RP, Taylor SN, Lu PY, Sartor BM, Storment JM, Rye PH, Pelletier WD, Zehnder JL, Matulich EM. Spontaneous reduction of multiple pregnancy: incidence and effect of outcome.  Amer J Obstet Gynecol 2002;186:77-83.
  23. Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH, Pyrzak R. Effect of diagnosis, age, sperm quality, and number of preovulatory follicles on the outcome of multiple cycles of clomiphene citrate-intrauterine insemination. Fertil Steril 2002, 78:1088-95.
  24. Dickey RP, Taylor, SN, Lu PY, Sartor BM, Pyrzak R. Clomiphene citrate  intrauterine insemination (IUI) before gonadotropin IUI affects the pregnancy rate and the rate of high-order multiple pregnancies. Fertil Steril 2003;81:545.
  25. Dickey RP, Lu PY, Sartor BM. Twins conceived through In-Vitro Fertilization.AJOG 2003 Aug, 189(2):513-8 (Letter).
  26. Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH, Pyrzak R. Risk factors for high-order multiple pregnancy and multiple birth after controlled ovarian hyperstimulation: results of 4,062 intrauterine insemination cycles. Fertil Steril. 2005 March;83(3):671-83.
  27. Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH. Is early embryonic crowding responsible for premature delivery and low birth weight of singleton pregnancies conceived by assisted reproductive technology? Amer J Obstet Gynecol 2005; 193:589-96. (Letter)
  28. Dickey RP, Lu PY, Sartor BM, Dunaway HE, Pyrzak R, Klumpp AM. Hurricane Katrina – Steps taken to protect and later rescue cryopreserved embryos are described. Fertil Steril 2006;86:732-4.

Presentations

  1. A comparison of elective and emergency cesarean hysterectomy at Louisiana State University in New Orleans from 1981 to 1991. Lu PY, Pastorek JG, Letellier RL, Bey MA.
  2. Oral presentation at the Annual Residents’ Research Day, Department of Obstetrics and Gynecology, Louisiana State University, New Orleans, June 28, 1993.
  3. Oral presentation at ACOG District VII Louisiana Section 14th Annual Meeting, New Orleans, Louisiana, March 12, 1993.
  4. Oral presentation at Southern Medical Association, 87th Scientific Assembly, New Orleans, October 29, 1993.
  5. Lu PY, Hammitt DG, Zinsmeister AR, Dewald GW.  Dual color fluorescence in situ hybridization (fish) of human sperm in 21 normal males and a man with 46,XY,t(2;4;8)(q23;q27;p21).
  6. Poster presentation at Society for Gynecologic Investigation, Forty-first Annual Scientific Meeting, Chicago, March 22-25, 1994.
  7. Oral presentation at Annual Residents’ Research Day, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota, June 18, 1994.
  8. Lu PY, Atkinson EJ, Chen ALJ, Lee SH, Erickson LD, Ory SJ.  Minimal stimulation achieves pregnancy rates comparable to human menopausal gonadotropins in the treatment of infertility.
  9. Oral presentation at the 50th Annual Meeting of the American Fertility Society, San Antonio, Texas, November 7, 1994.
  10. Oral presentation at Minnesota Obstetrical and Gynecological Society Fall Meeting, December 3, 1994.
  11. The impact of gender on alpha-methyl-para-tyrosine mediated changes in prolactin and melatonin secretion. Lu PY, Krahn L, Lin SC, Klee G, Ory SJ, Zimmermann RC.
  12. Poster presentation at The Society for Gynecologic Investigation, Forty-second Annual Scientific Meeting, Chicago, March 15-18, 1995.
  13. Ovarian Androgen  Production is not Affected by Sympathetic Nervous System (SNS) Suppression with Alpha-methyl-para-tyrosine (AMPT). Lu PY, Krahn L, Lin SC, Klee G, Ory SJ, Zimmermann RC.
  14. Oral presentation at Annual Residents’ Research Day, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota, June 17, 1995.
  15. Oral presentation at 51st Annual Meeting of the American Fertility Society, Seattle, October 10, 1995.
  16. Optimal Scheduling of Controlled Ovarian Hyperstimulation (COH) for In Vitro Fertilization. Lu PY, Hammitt DG, Erickson LD, Stevens S, Ory SJ.
  17. Oral presentation at 51st Annual Meeting of the American Fertility Society, Seattle, October 10, 1995.
  18. Fluorescence In Situ Hybridization (FISH) and Cytogenetic Analysis of Unfertilized Oocytes after Intracytoplasmic Sperm Injection (ICSI). Lu PY, Hammitt DG, Dewald GW, Walker DA, and Ory SJ. Accepted for oral presentation at The Society for Gynecologic Investigation, Forty-third Annual Scientific Meeting, Philadelphia, March 21, 1996.
  19. Fuorescence In Situ Hybridization (FISH) Sex Chromosome Analysis of Calcium Ionophore A23187 Parthogenetically Activated Oocytes.  Rhoton-Vlasic A, Lu PY Hammitt DH, Dewald GW, and Ory SJ. Accepted for poster presentation at The Society for Gynecologic Investigation, Forty-third Annual Scientific Meeting, Philadelphia, March 21, 1996.
  20. Pyrzak R, Dickey RP, Taylor SN, Curole DN, Rye PH, Lu PY, Potts AS, Walker MJ, Loll RC.  A practical sperm preparation procedure for ART, without using Percoll and centrifugation steps: implication for pregnancy outcome.
  21. Oral presentation at the American Association of Bioanalysts’ Annual Southeastern Meeting, San Antonio, TX, April 1997.
  22. Dickey RP, Taylor SN, Rye PH, Lu PY. Relationship of serum estradiol on the day of human chorionic gonadotropin to in vitro fertilization outcome.
  23. Oral presentation at the American Society for Reproductive Medicine’s Annual Meeting in San Francisco, CA, October 3-9, 1998.
  24. Dickey RP, Taylor SN, Rye PH, Lu PY.  Prediction of in vitro fertilization by estradiol after seven days of follicle stimulating hormone or human menopausal gonadotropin.
  25. Oral presentation at the American Society for Reproductive Medicine’s Annual Meeting in San Francisco, CA, October 3-9, 1998.
  26. Pyrzak R, Dickey RP, Sartor BM, Lu PY, Taylor SN, Rye PH.  Multiple pregnancy outcome in IVF-ET can be predicted by size of lead follicle at the time of hCG administration.
  27. Oral presentation at the American Society for Reproductive Medicine’s Annual Meeting in Toronto, Ontario, Canada, September 25-30, 1999.
  28. Pyrzak R, Dickey RP, Sartor BM, Lu PY, Taylor SN, Rye PH.  Relationship between lead follicular size and oocyte maturity in the cohort at the time of hCG administration.
  29. Poster presentation at the American Society for Reproductive Medicine’s Annual Meeting in Toronto, Ontario, Canada, September 25-30, 1999.
  30. Potts AS, Pyrzak R, Dickey RP, Taylor SN, Rye PH, Lu PY, Sartor BM.  Pronuclear pre-embryo morphology can predict pregnancy outcome.  Poster presentation at the American Society for Reproductive Medicine’s Annual Meeting in Toronto, Ontario, Canada, September 25-30, 1999.
  31. Dickey RP, Pyrzak R, Lu PY, Sartor BM, Taylor SN, Rye PH, Storment J. Comparison of hCG levels following transfer of embryos on the third day and fifth day post IVF.
  32. Poster presentation at the American Society for Reproductive Medicine’s Annual Meeting in San Diego, CA, October 21-26, 2000.
  33. Pyrzak R, Dickey RP, Sartor BM, Taylor SN, Lu PY, Storment JM.  Serum values of E2 and P4 adjusted to serum volume may change the evaluation outcome of ovarian response, treatment, and results of IVF patients when compared to the absolute values.
  34. Poster presentation at the American Society for Reproductive Medicine’s Annual Meeting in San Diego, CA, October 21-26, 2000.
  35. Sartor BM, Dickey RP, Taylor SN, Lu PY, Rye PH, Pyrzak P.  Oral contraceptives, not GNRH suppression, may be responsible for very low endogenous LH during IVF cycles.
  36. Poster presentation at the American Society for Reproductive Medicine’s Annual Meeting in Orlando, FL, 2001.
  37. Pyrzak PH, Dickey RP, Taylor SN, Lu PY, Sartor BM.  Comparison between GNRH agonist and antagonist on IVF outcome in relation to number of follicles on start day of hyperstimulation.
  38. Poster presentation at the American Society for Reproductive Medicine’s Annual Meeting in Orlando, FL, 2001.
  39. Pyrzak R, Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH. Pregnancy outcome and embryo quality depends on the serum progesterone levels on the first day of ovarian stimulation following in vitro fertilization.  Accepted for poster presentation at the Annual Meeting of the American Society for Reproductive Medicine, Seattle, WA, 2001
  40. Dickey RP, Pyrzak R, Lu PY, Sartor BM, Taylor SN, Storment JM. Pituitary-ovarian recovery after oral contraceptive use before in vitro fertilization.  Accepted for poster presentation at the Annual Meeting of the American Society for Reproductive Medicine, Seattle, WA, 2002.
  41. Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH, Pyrzak R. The number of cycles of gonadotropin-intrauterine insemination should be tailored to follicular response. Accepted for poster presentation at the Annual Meeting of the American Society for Reproductive Medicine. San Antonio, TX, 2003.
  42. Dickey RP, Taylor SN, Lu PY, Sartor BM, Pyrzak R. Effect on pregnancy rate and high order multiple pregnancy of clomiphene-intrauterine insemination before gonadotropin-intrauterine insemination.  Accepted for poster presentation at the Annual Meeting of the American Society for Reproductive Medicine.  San Antonio, TX, 2003.
  43. Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH, Pyrzak R. High order multiple pregnancy resulting from controlled ovarian hyperstimulation and intrauterine insemination can be predicted by the number of preovulatory follicles, estradiol levels, and age. Accepted for poster presentation at the Annual Meeting of the American Society for Reproductive Medicine. San Antonio, TX, 2003.
  44. Dickey RP, Taylor SN, Lu PY, Sartor BM, Dunaway HE. Can the number of antral follicles before the start of gonadotropin stimulation predict the number of preovulation follicles and total oocytes in IVF cycles?  Accepted for poster presentation at the Annual Meeting of the American Society of Reproductive Medicine.  Denver, CO, 2010.